Kidney Transplant Clinical Trials

163 recruitingLast updated: June 17, 2026

There are 163 actively recruiting kidney transplant clinical trials across 40 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Boston, Massachusetts, United States, Los Angeles, California, United States, New York, New York, United States. Updated daily from ClinicalTrials.gov.


Kidney Transplant Trials at a Glance

163 actively recruiting trials for kidney transplant are listed on ClinicalTrialsFinder across 6 cities in 40 countries. The largest study group is Not Applicable with 46 trials, with the heaviest enrollment activity in Boston, Los Angeles, and New York. Lead sponsors running kidney transplant studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, National Institute of Allergy and Infectious Diseases (NIAID), and Assistance Publique - Hôpitaux de Paris.

Browse kidney transplant trials by phase

Treatments under study

About Kidney Transplant Clinical Trials

Looking for clinical trials for Kidney Transplant? There are currently 48 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Kidney Transplant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Kidney Transplant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 163 trials

Recruiting

Access to Kidney Transplant of Obese Patients Beginning Dialysis

Obese PatientsComorbiditiesDialysis+1 more
Centre Hospitalier Universitaire, Amiens100 enrolled1 locationNCT04748770
Recruiting

The Mycophenolate Pregnancy Registry

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
Genentech, Inc.500 enrolled1 locationNCT01733082
Recruiting

Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA

Kidney Transplant Rejection
Virginia Commonwealth University50 enrolled1 locationNCT07415876
Recruiting
Phase 2

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

HypophosphatemiaKidney Transplantation
Stanford University90 enrolled1 locationNCT06824454
Recruiting
Phase 3

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

Cytomegalovirus InfectionsKidney Transplant InfectionPancreas Transplant
University of Wisconsin, Madison90 enrolled1 locationNCT06407232
Recruiting
Phase 3

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Kidney Transplant Failure and RejectionBK ViremiaKidney Transplant Infection
The University of Queensland280 enrolled13 locationsNCT05325008
Recruiting
Not Applicable

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

ObesityKidney Transplant; Complications
Virginia Commonwealth University30 enrolled1 locationNCT06688825
Recruiting
Early Phase 1

Tolerance Through Mixed Chimerism (Sip-Tego)

Kidney FailureTransplant Recipient (Kidney)Immunosuppresion+2 more
Tatsuo Kawai, MD, PhD12 enrolled1 locationNCT06972069
Recruiting
Phase 4

Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure

Acute Respiratory FailureKidney Transplant RecipientsSepsis and septic shock+1 more
University Hospital, Strasbourg, France212 enrolled1 locationNCT06881927
Recruiting
Phase 2Phase 3

A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

Kidney Transplant Rejection
Sanofi526 enrolled23 locationsNCT07412470
Recruiting
Phase 1Phase 2

Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)

Kidney TransplantationKidney Failure, ChronicAlloimmunization+3 more
Hospital Universitari Vall d'Hebron Research Institute10 enrolled1 locationNCT07607197
Recruiting

Trifecta-Kidney cfDNA-MMDx Study

Kidney Transplant Rejection
University of Alberta300 enrolled31 locationsNCT04239703
Recruiting
Phase 1Phase 2

Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

Kidney TransplantationXenotransplantationESRD (End-Stage Renal Disease)
United Therapeutics50 enrolled1 locationNCT07224763
Recruiting
Phase 4

Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients

Old AgeKidney Transplant Recipients
Massachusetts General Hospital92 enrolled1 locationNCT06751992
Recruiting

Vascular Complications After Kidney Transplantation

Heart FailureKidney Transplant; ComplicationsRenovascular Hypertension+4 more
University of Aarhus60 enrolled3 locationsNCT07531966
Recruiting
Phase 1

Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

Kidney Transplant Rejection
National Institute of Allergy and Infectious Diseases (NIAID)25 enrolled10 locationsNCT06918990
Recruiting
Not Applicable

TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation

CancerInfectionKidney Transplantation+1 more
Hospices Civils de Lyon600 enrolled4 locationsNCT06829719
Recruiting
Phase 2

Advancing Transplantation Outcomes in Children

Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled20 locationsNCT06055608
Recruiting
Not Applicable

Double Voiding and Post-transplant UTI

Kidney Transplant; ComplicationsUrinary Tract Infections
Weill Medical College of Cornell University438 enrolled1 locationNCT05711446
Recruiting
Phase 1

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Kidney TransplantKidney FailureEnd Stage Renal Failure on Dialysis
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled3 locationsNCT06056102